When CXCL12 expression is low, breast cancer cells promote migration via activating RhoA, while high concentrations allow the interaction between RhoA and Rac1, promoting cell–cell and cell–matrix adhesion and thus inhibiting migration [133]. Here, RHOA is linked to breast cancer.